Ankilozan spondilitli hastalarda komorbidite profilleri

Yesim Garip; Filiz Eser; Tuba Guler; Tuba Guler; Fulya Dortbas; Fulya Dortbas; Aysegul Kılıcarslan; Aysegul Kilicarslan; Hatice Bodur

doi:10.5472/MMJoa.2901.04

Ankilozan spondilitli hastalarda komorbidite profilleri

Abstract

Amaç: Ankilozan spondilit (AS) hastalarındaki komorbiditeleri ve klinik parametrelerle ilişkisini değerlendirmeyi amaçladık. Hastalar ve Yöntem: Çalışmaya 110 AS hastası dahil edildi. Hastalık aktivitesi Bath Ankilozan Spondilit Hastalık Aktivite İndeksi [Bath Ankylosing Disease Activity Index (BASDAI)] ile, fonksiyonel durum Bath Ankilozan Spondilit Fonksiyonel İndeks [Bath Ankylosing Spondylitis Functional Index (BASFI)] ile, spinal mobilite Bath Ankilozan Spondilit Metroloji İndeksi [Bath Ankylosing Spondylitis Metrology Index (BASMI)] ile ve yaşam kalitesi ise Nottingham Sağlık Profili [Nottingham Health Profile (NHP)] ile değerlendildi. Bulgular: Hastaların %28,18’inde komorbidite saptandı. Bunlar sırası ile peptik ülser (20,91%), hipertansiyon (%20), akciğer hastalığı (%15,45), diabetes mellitus (%13,64), osteoporoz (%10,91), iskemik kalp hastalığı (%10), böbrek hastalıkları (Ig A nefropatisi ve renal papiller nekroz, %1,82) ve kanserler (papiller tiroid kanseri ve renal hücreli kanser, %1,82) idi. Komorbiditesi bulunan hastalar BASDAI, BASMI, BASFI, VAS-ağrı ve NHP’nin ağrı, fiziksel mobilite ve enerji alt gruplarında belirgin olarak yüksek skorlama gösterdiler (p

Keywords

Ankilozan spondilit, Komorbidite, Hastalık aktivitesi, Yaşam kalitesi

References

1. Braun J, Sieper J Ankylosing spondylitis. Lancet 2007; 369: 1379-90.
2. Gensler L. Clinical features of ankylosing spondylitis. In: MC Hochberg, AJ Silman, JS Smolen, ME Weinblatt, MH Weisman, editors. Rheumatology. 5th ed. Philadelphia: Mosby Elsevier, 2009: 1129-34.
3. Kang JH, Chen YH, Lin HC. Comorbidity profiles among patients with ankylosing spondylitis: a nationwide populationbased study. Ann Rheum Dis 2010;69: 1165-8. doi: 10.1136/ ard.2009.116178.
4. Bremander A, Petersson IF, Bergman S, Englund M. Population-based estimates of common comorbidities and cardiovascular disease in ankylosing spondylitis. Arthritis Care Res (Hoboken) 2011;63:550-6. doi: 10.1002/acr.20408.
5. Study protocol for the World Health Organization project to develop a Quality of Life assessment instrument (WHOQOL). Qual Life Res 1993;2:153-9.
6. Fortin M, Dubois MF, Hudon C, Soubhi H, Almirall J. Multimorbidity and quality of life: a closer look. Health Qual Life Outcomes 2007;5:52. doi: 10.1186/1477-7525-5- 52
7. Stolwijk C, van Tubergen A, Ramiro S, et al. Aspects of validity of the self-administered comorbidity questionnaire in patients with ankylosing spondylitis. Rheumatology (Oxford) 2014;53:1054-64.
8. Mercieca C, van der Horst-Bruinsma IE, Borg AA. Pulmonary, renal and neurological comorbidities in patients with ankylosing spondylitis; implications for clinical practice. Curr Rheumatol Rep 2014;16:434. doi: 10.1007/s11926-014- 0434-7.

9. Moll JM. New criteria for the diagnosis of ankylosing spondylitis. Scand J Rheumatol Suppl 1987;65:12-24
10. Sieper J, Rudwaleit M, Baraliakos X, et al. The Assessment of SpondyloArthritis International Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009;68:1- 44. doi:10.1136/ard.2008.104018
11. Price DD, McGrath P, Rafii A, Buckingham B. The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 1983; 17:45-56.
12. Akkoc Y, Karatepe AG, Akar S, Kirazli Y, Akkoc N. A Turkish version of the Bath Ankylosing Spondylitis Disease Activity Index: reliability and validity. Rheumatol Int 2005;25:280-4.
13. Calin A, Garrett S, Whitelock H, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994;21:2281-5
14. Küçükdeveci AA, Mc Kenna SP, Kutlay S, Gürsel Y, Whalley D, Arasil T. The development and psycometric assessment of the Turkish version of the Nottingham Health Profile. Int J Rehabil Res 2000;23:31-8
15. Jenkinson TR, Mallorie PA, Whitelock HC, Kennedy LG, Garrett SL, Calin A. Defining spinal mobility in ankylosing spondylitis (AS): The Bath AS Metrology Index. J Rheumatol 1994;21:1694-8.
16. Bodur H, Ataman S, Buğdaycı DS, et al. Description of the registry of patients with ankylosing spondylitis in Turkey: TRASD-IP. Rheumatol Int 2012;32:169-76. doi: 10.1007/ s00296-010-1599-7
17. Casals-Sánchez JL, García De Yébenes Prous MJ, Descalzo Gallego MÁ, et al. Characteristics of patients with spondyloarthritis followed in rheumatology units in Spain. emAR II study. Reumatol Clin 2012;8:107-13
18. Ara RM, Packham JC, Haywood KL. The direct healthcare costs associated with ankylosing spondylitis patients attending a UK secondary care rheumatology unit. Rheumatology (Oxford) 2008;47:68-71.
19. Bostan EE, Borman P, Bodur H, Barca N. Functional disability and quality of life in patients with ankylosing spondylitis. Rheumatol Int 2003; 23: 121-6.
20. Brunner R, Kissling RO, Auckenthaler C, Fortin J. Clinical evaluation of ankylosing spondylitis in Switzerland. Pain Physician 2002; 5: 49-56.
21. Collantes E, Zarco P, Muñoz E, et al. Disease pattern of spondyloarthropathies in Spain: description of the first national registry (REGISPONSER) extended report. Rheumatology (Oxford) 2007;46:1309-15.
22. Tayel MY, Soliman E, El Baz WF, El Labaan A, Hamaad Y,Ahmed MH. Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population. Rheumatol Int 2012; 32:2837-42. doi: 10.1007/s00296-011-2068-7
23. Ariza-Ariza R, Hernández-Cruz B, López-Antequera G, Navarro-Sarabia F. Variables related to utility in patients with ankylosing spondylitis. Clin Rheumatol 2009;28: 207- 11. doi: 10.1007/s10067-008-1019-5
24. Boonen A, Chorus A, Miedema H, et al. Withdrawal from labour force due to work disability in patients with ankylosing spondylitis. Ann Rheum Dis 2001; 60: 1033-9.
25. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 2009;7:25. doi: 10.1186/1477-7525-7-25

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Yesim Garip

Filiz Eser This is me

Tuba Guler This is me

Fulya Dortbas This is me

Aysegul Kılıcarslan This is me

Aysegul Kilicarslan This is me

Hatice Bodur This is me

Publication Date

March 4, 2016

Submission Date

March 4, 2016

Acceptance Date

-

Published in Issue

Year 2016 Volume: 29 Number: 1

DOI

https://doi.org/10.5472/MMJoa.2901.04

IZ

https://izlik.org/JA49HM64AM

Cite

RIS / Bibtex

APA

Garip, Y., Eser, F., Guler, T., Guler, T., Dortbas, F., Dortbas, F., Kılıcarslan, A., Kilicarslan, A., & Bodur, H. (2016). Ankilozan spondilitli hastalarda komorbidite profilleri. Marmara Medical Journal, 29(1), 23-28. https://doi.org/10.5472/MMJoa.2901.04

AMA

1.Garip Y, Eser F, Guler T, et al. Ankilozan spondilitli hastalarda komorbidite profilleri. Marmara Med J. 2016;29(1):23-28. doi:10.5472/MMJoa.2901.04

Chicago

Garip, Yesim, Filiz Eser, Tuba Guler, et al. 2016. “Ankilozan Spondilitli Hastalarda Komorbidite Profilleri”. Marmara Medical Journal 29 (1): 23-28. https://doi.org/10.5472/MMJoa.2901.04.

EndNote

Garip Y, Eser F, Guler T, Guler T, Dortbas F, Dortbas F, Kılıcarslan A, Kilicarslan A, Bodur H (March 1, 2016) Ankilozan spondilitli hastalarda komorbidite profilleri. Marmara Medical Journal 29 1 23–28.

IEEE

[1]Y. Garip et al., “Ankilozan spondilitli hastalarda komorbidite profilleri”, Marmara Med J, vol. 29, no. 1, pp. 23–28, Mar. 2016, doi: 10.5472/MMJoa.2901.04.

ISNAD

Garip, Yesim - Eser, Filiz - Guler, Tuba - Guler, Tuba - Dortbas, Fulya - Dortbas, Fulya - Kılıcarslan, Aysegul - Kilicarslan, Aysegul - Bodur, Hatice. “Ankilozan Spondilitli Hastalarda Komorbidite Profilleri”. Marmara Medical Journal 29/1 (March 1, 2016): 23-28. https://doi.org/10.5472/MMJoa.2901.04.

JAMA

1.Garip Y, Eser F, Guler T, Guler T, Dortbas F, Dortbas F, Kılıcarslan A, Kilicarslan A, Bodur H. Ankilozan spondilitli hastalarda komorbidite profilleri. Marmara Med J. 2016;29:23–28.

MLA

Garip, Yesim, et al. “Ankilozan Spondilitli Hastalarda Komorbidite Profilleri”. Marmara Medical Journal, vol. 29, no. 1, Mar. 2016, pp. 23-28, doi:10.5472/MMJoa.2901.04.

Vancouver

1.Yesim Garip, Filiz Eser, Tuba Guler, Tuba Guler, Fulya Dortbas, Fulya Dortbas, Aysegul Kılıcarslan, Aysegul Kilicarslan, Hatice Bodur. Ankilozan spondilitli hastalarda komorbidite profilleri. Marmara Med J. 2016 Mar. 1;29(1):23-8. doi:10.5472/MMJoa.2901.04

Cited By

Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis

Rheumatology

https://doi.org/10.1093/rheumatology/keaa246

Diabetes mellitus in ankylosing spondylitis

Annals of the Rheumatic Diseases

https://doi.org/10.1136/annrheumdis-2019-216221

Uveitis increases the risk of stroke among patients with ankylosing spondylitis: A nationwide population-based longitudinal study

Frontiers in Immunology

https://doi.org/10.3389/fimmu.2022.959848

Prevalence of Comorbidities and Racial Disparities in Anterior Uveitis Risk Among Ankylosing Spondylitis Patients

Apollo Medicine

https://doi.org/10.1177/09760016241309975